← Leaderboards
Jianping Huang
University Of Florida
$1,345,181
Attributed
$1,345,181
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,345,181 · 4
By mechanism
R41$797,994 · 2
R21$394,687 · 1
R03$152,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Tumor”
- Kenneth Schultz · Trethera Corporation$7,146,643
- Jeff P Simko · Washington University$4,848,843
- Gary G Schwartz · University Of North Dakota$4,000,000
- Yicheng Wang · Immunova Therapeutics, Llc$4,000,000
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Daniel Francis · Claria Medical, Inc.$3,708,259
Research focus
TumorPhenotypeAffectT-LymphocyteCancer ImmunotherapyCellsImmuneMalignant NeoplasmsAffinityTumor ProgressionClinical ApplicationBindingBrain NeoplasmsInsightAntibodiesImmune CheckpointGenesChimeric Antigen Receptor T CellsGliomaImmune ResponseCar T Cell TherapyCd8-Positive T-LymphocytesAntitumor ResponseCell Communication
Grant awards (5)
Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305$398,997
R41 · FY2025 · CA · contact PI
Enhance Cancer Therapeutics with 3-in-1 CAR T Cells$398,997
R41 · FY2025 · CA · contact PI
Enhancing antitumor efficacy by intratumoral delivering LAIR1 inhibitory signaling$394,687
R21 · FY2025 · CA · contact PI
SPDYE3, A Novel Cancer Testis (CT) Antigen for Glioma Immunotherapy$76,250
R03 · FY2023 · CA · contact PI
SPDYE3, A Novel Cancer Testis (CT) Antigen for Glioma Immunotherapy$76,250
R03 · FY2022 · CA · contact PI